NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Takeda
City of Hope Medical Center
Merck Sharp & Dohme LLC
City of Hope Medical Center
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Tempus AI
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Sichuan Enray Pharmaceutical Sciences Company
Elevation Oncology
Intensity Therapeutics, Inc.
Stanford University
Novartis
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NantCell, Inc.
Pfizer
ADC Therapeutics S.A.
Exelixis
Eli Lilly and Company
Pfizer
University Hospital, Ghent
pharmaand GmbH
Hoffmann-La Roche
Genmab
Corcept Therapeutics
Gilead Sciences
Novartis
Bristol-Myers Squibb
Gilead Sciences
National Institutes of Health Clinical Center (CC)
Ipsen
Stanford University
Pfizer
Pharmacyclics LLC.
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
GlaxoSmithKline
Amgen
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
INSYS Therapeutics Inc